Pediatrics
- Massachusetts General Hospital & Harvard Medical,
2000
Board Certifications
American Board of Pediatrics/Hematology-Oncology
American Board of Pediatrics/General Pediatrics
Healthcare Delivery/Implementation
Oncology
Outcomes
Indelicato, D. J., Vega, R. B. M., Viviers, E., Morris, C. G., Bradfield, S. M., Ranalli, N. J., & Bradley, J. A. (2022). Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: An Update of the University of Florida Experience. International Journal of Radiation Oncology Biology Physics. doi:10.1016/j.ijrobp.2022.01.007 View Full Publication
Parekh, A. D., Indelicato, D. J., Vega, R. B. M., Rotondo, R. L., Morris, C. G., Bradfield, S., & Bradley, J. A. (2021). Proton radiotherapy for infant rhabdomyosarcoma: Rethinking young age as an adverse prognostic factor. Radiotherapy and Oncology, 163, 215-220. doi:10.1016/j.radonc.2021.05.017 View Full Publication
Schultz, K. A. P., Nelson, A., Harris, A. K., Finch, M., Field, A., Jarzembowski, J. A., & Ashley Hill, D. (2020). Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation. Modern Pathology, 33(10), 1922-1929. doi:10.1038/s41379-020-0558-4 View Full Publication
Uezono, H., Indelicato, D. J., Rotondo, R. L., Mailhot Vega, R. B., Bradfield, S. M., Morris, C. G., & Bradley, J. A. (2020). Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis. International Journal of Radiation Oncology Biology Physics, 107(5), 974-981. doi:10.1016/j.ijrobp.2020.04.043 View Full Publication
Indelicato, D. J., Rotondo, R. L., Krasin, M. J., Mailhot Vega, R. B., Uezono, H., Bradfield, S., & Bradley, J. A. (2020). Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma. International Journal of Radiation Oncology Biology Physics, 106(5), 968-976. doi:10.1016/j.ijrobp.2019.12.036 View Full Publication
Kharod, S. M., Indelicato, D. J., Rotondo, R. L., Mailhot Vega, R. B., Uezono, H., Morris, C. G., & Bradley, J. A. (2020). Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base. Pediatric Blood and Cancer, 67(2). doi:10.1002/pbc.28080 View Full Publication
Ruland, M. O., Egelund, T. A., Ng, J. S., Bradfield, S. M., & Egelund, E. F. (2019). Intravenous and oral posaconazole pharmacokinetics in a five-year-old with mucor: A case report and review of the literature. Journal of Pediatric Pharmacology and Therapeutics, 24(6), 528-533. doi:10.5863/1551-6776-24.6.528
Indelicato, D. J., Rotondo, R. L., Mailhot Vega, R. B., Uezono, H., Bradfield, S., Agarwal, V., & Bradley, J. A. (2019). 45 GyRBE for group III orbital embryonal rhabdomyosarcoma. Acta Oncologica, 58(10), 1404-1409. doi:10.1080/0284186X.2019.1627412 View Full Publication
Agarwal, V., Logie, N., Morris, C. G., Bradley, J. A., Rotondo, R. L., Bradfield, S. M., & Indelicato, D. J. (2018). Esophagitis associated with multimodality management of pediatric Ewing sarcoma of thorax. Pediatric Blood and Cancer, 65(6). doi:10.1002/pbc.27006 View Full Publication
Bechtel, A. S., Cheek, B., & Bradfield, S. (2018). False Lung Metastasis: Concurrent Ewing Sarcoma and Minimally Invasive Adenocarcinoma. Journal of Pediatric Hematology/Oncology, 40(4), 325-327. doi:10.1097/MPH.0000000000000980 View Full Publication
Bradfield, S. M., Sandler, E., Geller, T., Tamura, R. N., & Krischer, J. P. (2015). Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer. Pediatric Blood and Cancer, 62(6), 1004-1010. doi:10.1002/pbc.25384 View Full Publication
Choose a Region
Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.